Indication
Von Willebrand's disease
Von Willebrand's disease is the most common inherited bleeding disorder, affecting the hematologic system in both males and females. Read more about Von Willebrand's disease
31 drugs 28 manufacturers
Drugs that treat it
Common Von Willebrand's disease therapies.
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
DESMOPRESSIN ACETATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVon Willebrand's disease is the most common inherited bleeding disorder, affecting the hematologic system in both males and females.
It is characterized by a quantitative deficiency or qualitative dysfunction of von Willebrand factor, an essential multimeric plasma glycoprotein required for platelet adhesion to damaged vascular endothelium and for stabilizing coagulation factor VIII.
Clinically, affected individuals typically present with mucocutaneous bleeding—such as epistaxis, easy bruising, gingival hemorrhage, gastrointestinal bleeding, and heavy menstrual bleeding—as well as prolonged hemorrhage following surgery, dental procedures, or trauma.
- nih.gov
Von Willebrand's disease is the most common inherited bleeding disorder, affecting the hematologic system in both males and females
- nih.gov
It is characterized by a quantitative deficiency or qualitative dysfunction of von Willebrand factor, an essential multimeric plasma glycoprotein required for platelet adhesion to damaged vascular endothelium and for stabilizing coagulation factor VIII Clinically, affected individuals typically present with mucocutaneous bleeding—such as epistaxis, easy bruising, gingival hemorrhage, gastrointestinal bleeding, and heavy menstrual bleeding—as well as prolonged hemorrhage following surgery, dental...
- nih.gov
It is characterized by a quantitative deficiency or qualitative dysfunction of von Willebrand factor, an essential multimeric plasma glycoprotein required for platelet adhesion to damaged vascular endothelium and for stabilizing coagulation factor VIII
- nih.gov
It is characterized by a quantitative deficiency or qualitative dysfunction of von Willebrand factor, an essential multimeric plasma glycoprotein required for platelet adhesion to damaged vascular endothelium and for stabilizing coagulation factor VIII
Personalize your experience
Follow Von Willebrand's disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.